Kymera Therapeutics, Inc. — All Filings
540 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
EFFECT
S-1
S-1/A
S-1MEF
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 8-K | 8-K | 0001193125-26-129170 | Mar 27, 2026 | Mar 25, 2026 |
| SCHEDULE 13G/A | — | 0000102909-26-001649 | Mar 27, 2026 | — |
| 4 | 4 | 0001193125-26-124367 | Mar 25, 2026 | Mar 23, 2026 |
| 144 | — | 0001950047-26-002913 | Mar 23, 2026 | — |
| 4 | 4 | 0001193125-26-118032 | Mar 20, 2026 | — |
| 144 | — | 0001950047-26-002864 | Mar 20, 2026 | — |
| 4 | 4 | 0001193125-26-102630 | Mar 11, 2026 | — |
| 144 | — | 0001950047-26-002488 | Mar 11, 2026 | — |
| 4 | 4 | 0001193125-26-091986 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-091985 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-091984 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-091983 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-091982 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | 4 | 0001193125-26-091980 | Mar 4, 2026 | Mar 2, 2026 |
| 4 | — | 0001451612-26-000002 | Mar 4, 2026 | Mar 2, 2026 |
| 144 | — | 0001628280-26-013331 | Mar 2, 2026 | — |
| 144 | — | 0001628280-26-013330 | Mar 2, 2026 | — |
| 144 | — | 0001193125-26-085708 | Mar 2, 2026 | — |
| 144 | — | 0001193125-26-085705 | Mar 2, 2026 | — |
| 144 | — | 0001193125-26-085696 | Mar 2, 2026 | — |
| 8-K | 8-K | 0001193125-26-073561 | Feb 26, 2026 | — |
| 424B3 | 424B3 | 0001193125-26-073553 | Feb 26, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-073542 | Feb 26, 2026 | — |
| S-8 | S-8 | 0001193125-26-073431 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001193125-26-073395 | Feb 26, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-26-073386 | Feb 26, 2026 | — |
| 4 | 4 | 0001193125-26-072155 | Feb 25, 2026 | — |
| 144 | — | 0001969223-26-000229 | Feb 25, 2026 | — |
| 4 | 4 | 0001193125-26-061686 | Feb 20, 2026 | — |
| 144 | — | 0001950047-26-001590 | Feb 20, 2026 | — |
| SCHEDULE 13G/A | — | 0000902219-26-000017 | Feb 10, 2026 | — |
| 4 | 4 | 0001193125-26-016934 | Jan 20, 2026 | — |
| 144 | — | 0001950047-26-000560 | Jan 20, 2026 | — |
| 8-K | 8-K | 0001193125-26-011104 | Jan 13, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-26-000053 | Jan 8, 2026 | — |
| 4 | 4 | 0001193125-26-004641 | Jan 6, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-25-338415 | Dec 31, 2025 | — |
| 144 | — | 0001969223-25-001120 | Dec 31, 2025 | — |
| 4 | 4 | 0001193125-25-323092 | Dec 17, 2025 | — |
| 4 | 4 | 0001193125-25-323090 | Dec 17, 2025 | — |
| 144 | — | 0001950047-25-010458 | Dec 17, 2025 | — |
| SCHEDULE 13D/A | — | 0000921895-25-003346 | Dec 15, 2025 | — |
| 4 | — | 0001451612-25-000014 | Dec 12, 2025 | Dec 10, 2025 |
| 144 | — | 0001178937-25-000093 | Dec 12, 2025 | — |
| 144 | — | 0001178937-25-000092 | Dec 12, 2025 | — |
| SCHEDULE 13D/A | — | 0001104659-25-120356 | Dec 11, 2025 | — |
| 144 | — | 0001178937-25-000090 | Dec 11, 2025 | — |
| 144 | — | 0001178937-25-000089 | Dec 11, 2025 | — |
| 4 | 4 | 0001193125-25-315999 | Dec 11, 2025 | — |
| 144 | — | 0001178937-25-000088 | Dec 10, 2025 | — |